BraveNet Integrative Medicine Descriptive Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Duke University
Related studies linked through entity extraction aliases.
CONNECT for Quality: A Study to Reduce Falls in Nursing Homes
- Status
- COMPLETED
- Phase
- NA
Escitalopram Treatment of Night Eating Syndrome
- Status
- COMPLETED
- Phase
- NA
Feasibility of Exercise With Post-Op Lung Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Inattention in Childhood Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Genetics of Spina Bifida and Anencephaly
- Status
- COMPLETED
- Phase
- N/A
Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001
- Status
- COMPLETED
- Phase
- N/A
Guided Imagery for Military Sexual Trauma-Related Posttraumatic Stress Disorder (PTSD)
- Status
- COMPLETED
- Phase
- NA
DAMES: Daughters And MothErS Against Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients
- Status
- COMPLETED
- Phase
- NA
Computerized Cognitive Training for Childhood Cancer Survivors
- Status
- TERMINATED
- Phase
- NA
Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Exercise Training Among Men With Prostate Cancer
- Status
- WITHDRAWN
- Phase
- NA
The Role of Intra-Operative Intracapsular Blocks in Post-Operative Pain Management Following Total Knee Arthroplasty
- Status
- COMPLETED
- Phase
- PHASE4
Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
- Status
- COMPLETED
- Phase
- PHASE2
Genetics of Peripheral Artery Genomics
- Status
- COMPLETED
- Phase
- N/A
Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
- Status
- COMPLETED
- Phase
- PHASE2